AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to hospitals and healthcare facilities in the United States. The company operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. It offers travel nurse staffing under the American Mobile, Onward Healthcare, and O'Grady Peyton brands; rapid response nurse staffing and labor disruption services under the NurseChoice and HealthSource Global Staffing brands; local or per diem staffing services under Nursefinders brand; and locum tenens staffing services under the Staff Care and Locum Leaders brands. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists under the Med Travelers and Club Staffing brands; revenue cycle solutions; physician permanent placement services to hospitals, healthcare facilities, and physician practice groups; interim leadership staffing and executive search services; and recruitment process outsourcing services. In addition, it offers managed services programs; language interpretation services; vendor management systems; workforce optimization services; credentialing services; digital staffing services; and flex pool management services. AMN Healthcare Services, Inc. was founded in 1985 and is based in Dallas, Taxas.
IPO Year:
Exchange: NYSE
Website: amnhealthcare.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/8/2024 | Outperform → Mkt Perform | William Blair | |
| 10/7/2024 | $65.00 → $48.00 | Neutral → Underperform | BofA Securities |
| 12/6/2023 | $85.00 | Mkt Outperform | JMP Securities |
| 11/3/2023 | $115.00 → $70.00 | Buy → Hold | Jefferies |
| 11/3/2023 | Buy → Hold | The Benchmark Company | |
| 8/4/2023 | $112.00 → $104.00 | Buy → Neutral | BofA Securities |
| 2/18/2022 | $140.00 → $170.00 | Buy | Jefferies |
| 2/18/2022 | $125.00 → $140.00 | Buy | Benchmark |
| 11/17/2021 | $115.00 → $139.00 | Outperform | Credit Suisse |
| 11/8/2021 | $115.00 → $127.00 | Outperform | BMO Capital |
8-K - AMN HEALTHCARE SERVICES INC (0001142750) (Filer)
8-K - AMN HEALTHCARE SERVICES INC (0001142750) (Filer)
8-K - AMN HEALTHCARE SERVICES INC (0001142750) (Filer)
8-K - AMN HEALTHCARE SERVICES INC (0001142750) (Filer)
10-Q - AMN HEALTHCARE SERVICES INC (0001142750) (Filer)
8-K - AMN HEALTHCARE SERVICES INC (0001142750) (Filer)
8-K - AMN HEALTHCARE SERVICES INC (0001142750) (Filer)
8-K - AMN HEALTHCARE SERVICES INC (0001142750) (Filer)
8-K - AMN HEALTHCARE SERVICES INC (0001142750) (Filer)
DEF 14A - AMN HEALTHCARE SERVICES INC (0001142750) (Filer)
3 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4/A - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
3 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
SC 13G/A - AMN HEALTHCARE SERVICES INC (0001142750) (Subject)
SC 13G/A - AMN HEALTHCARE SERVICES INC (0001142750) (Subject)
SC 13G/A - AMN HEALTHCARE SERVICES INC (0001142750) (Subject)
SC 13G - AMN HEALTHCARE SERVICES INC (0001142750) (Subject)
SC 13G/A - AMN HEALTHCARE SERVICES INC (0001142750) (Subject)
SC 13G - AMN HEALTHCARE SERVICES INC (0001142750) (Subject)
SC 13G/A - AMN HEALTHCARE SERVICES INC (0001142750) (Subject)
SC 13G/A - AMN HEALTHCARE SERVICES INC (0001142750) (Subject)
SC 13G/A - AMN HEALTHCARE SERVICES INC (0001142750) (Subject)
William Blair downgraded AMN Healthcare from Outperform to Mkt Perform
BofA Securities downgraded AMN Healthcare from Neutral to Underperform and set a new price target of $48.00 from $65.00 previously
JMP Securities initiated coverage of AMN Healthcare with a rating of Mkt Outperform and set a new price target of $85.00
Jefferies downgraded AMN Healthcare from Buy to Hold and set a new price target of $70.00 from $115.00 previously
The Benchmark Company downgraded AMN Healthcare from Buy to Hold
BofA Securities downgraded AMN Healthcare from Buy to Neutral and set a new price target of $104.00 from $112.00 previously
Jefferies reiterated coverage of AMN Healthcare Services with a rating of Buy and set a new price target of $170.00 from $140.00 previously
Benchmark reiterated coverage of AMN Healthcare Services with a rating of Buy and set a new price target of $140.00 from $125.00 previously
Credit Suisse reiterated coverage of AMN Healthcare Services with a rating of Outperform and set a new price target of $139.00 from $115.00 previously
BMO Capital reiterated coverage of AMN Healthcare Services with a rating of Outperform and set a new price target of $127.00 from $115.00 previously
DALLAS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare, the leader and innovator in total talent solutions for healthcare organizations, announces it has approved near and long-term science-based emissions reduction targets with the Science Based Targets initiative (SBTi), joining over 4,000 companies globally in the pursuit of net zero emissions. This decisive move underscores AMN Healthcare's dedication to sustainability and proactive measures against climate change. AMN Healthcare has set near- and long-term goals to significantly reduce greenhouse gas (GHG) emissions across its operations and value chain. With a clear alignment to global efforts like the 2015 Paris Agreement, AMN ai
Quarterly revenue of $688 million; GAAP EPS of $0.18 and adjusted EPS of $0.61 DALLAS, Nov. 07, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its third quarter 2024 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts. Q3 2024% Change Q3 2023YTD September 30, 2024% Change YTD September 30, 2023Revenue$687.5(19%)$2,249.1(24%)Gross profit$213.1(26%)$700.4(29%)Net income$7.0(87%)$40.6(80%)GAAP diluted EPS$0.18(87%)$1.06(79%)Adjusted diluted EPS*$0.61(69%)$2.56(63%)Adjusted EBITDA*$73.9(45%)$265.6
DALLAS, Oct. 31, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE:AMN), the leader and innovator in total talent solutions for healthcare organizations, today announced the appointment of Tomya Watt as Chief People Officer effective January 13, 2025. With more than two decades of strategic and operational experience in healthcare and talent solutions, Ms. Watt is well-equipped to guide the company's human resources function into a new era of sustainable growth. "We are thrilled to welcome Tomya Watt to AMN Healthcare," said Cary Grace, AMN Healthcare's President and CEO. "Our exceptional team and culture distinguish us in the industry. Tomya's visionary leadership and extensive expertise
DALLAS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN) ("AMN" or "the Company"), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced that Brian Scott has been appointed Chief Financial Officer and Chief Operating Officer, effective November 21, 2024. In this role, Mr. Scott will be responsible for AMN's finance and enterprise operating functions as the Company continues to evolve its model to be more automated and scaled. Mr. Scott is returning to AMN, where he previously held a variety of roles of increasing responsibility in finance, strategy and accounting over his 17-year tenure, includin
DALLAS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare today launched WorkWise, an innovative technology suite that unifies its technologies into one single technology offering. By combining the capabilities of quantifying staffing demand with predictive scheduling, automated workforce management, and enhanced clinician engagement using AI technology, it is designed to streamline workforce processes, empowering healthcare systems to efficiently source the right talent at the right time, while effectively managing costs. Completely integrated with healthcare organizations' internal systems, hospitals will be able to optimize personnel for any type of job (permanent, per diem, contract),
Jeffrey Knudson to Step Down as CFO Following Company's Q3 Report Company Expects to Announce New Leader in Expanded CFO/COO Role Prior to November 8 Reaffirms Third Quarter 2024 Outlook DALLAS, Oct. 01, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN) ("AMN" or "the Company"), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced that Jeffrey Knudson will step down from his role as Chief Financial Officer, effective November 8, 2024, to pursue an opportunity with a private company outside of the healthcare staffing industry. AMN expects to announce a new leader in an expanded Chief Financial Officer/C
DALLAS, Sept. 30, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), has scheduled a conference call to discuss its third quarter 2024 financial results and fourth quarter 2024 outlook on Thursday, November 7, 2024, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time. A live webcast of the call can be accessed through this webcast link, which also will be available on AMN Healthcare's investor relations website. Interested parties may participate live via telephone by registering at this conference call link. Please follow the link and register with a valid e-mail
DALLAS, Aug. 27, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Language Services (AMN LS), a leading provider of language solutions for the healthcare industry, today announced the launch of its newest offering – Strategic Partnership Solutions (SPS) – created to transform language access programs in healthcare organizations by providing comprehensive language services and strategic support to organizations. SPS will take on the operational responsibility as an in-house language service department for health systems and organizations by partnering with healthcare providers. Through the offering, an organization can gain access to a range of core language services, including video remote interpr
Quarterly revenue of $741 million; GAAP EPS of $0.42 and adjusted EPS of $0.98 DALLAS, Aug. 08, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its second quarter 2024 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts. Q2 2024% Change Q2 2023YTD June 30, 2024% Change YTD June 30, 2023Revenue$740.7(25%)$1,561.6(26%)Gross profit$229.8(30%)$487.3(30%)Net income$16.2(73%)$33.6(77%)GAAP diluted EPS$0.42(73%)$0.88(75%)Adjusted diluted EPS*$0.98(59%)$1.95(60%)Adjusted EBITDA*$94.1(42%)$191.8(44%) * See "
DALLAS, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Orthopedic surgeons are offered the highest average starting salary among physicians at $686,000, while pediatricians are at the low end of the starting salary scale at $244,000, according to an annual report from AMN Healthcare's Physician Solutions division (formerly known as Merritt Hawkins). The 2024 Review of Physician and Advanced Practitioner Recruiting Incentives, now in its 31st year, tracks starting salaries and other incentives offered by hospitals and medical groups to physicians, nurse practitioners (NPs) and other advanced practice professionals. Specialists are offered the top starting salaries among physicians, according to the rep
Quarterly revenue of $688 million; GAAP EPS of $0.18 and adjusted EPS of $0.61 DALLAS, Nov. 07, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its third quarter 2024 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts. Q3 2024% Change Q3 2023YTD September 30, 2024% Change YTD September 30, 2023Revenue$687.5(19%)$2,249.1(24%)Gross profit$213.1(26%)$700.4(29%)Net income$7.0(87%)$40.6(80%)GAAP diluted EPS$0.18(87%)$1.06(79%)Adjusted diluted EPS*$0.61(69%)$2.56(63%)Adjusted EBITDA*$73.9(45%)$265.6
DALLAS, Sept. 30, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), has scheduled a conference call to discuss its third quarter 2024 financial results and fourth quarter 2024 outlook on Thursday, November 7, 2024, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time. A live webcast of the call can be accessed through this webcast link, which also will be available on AMN Healthcare's investor relations website. Interested parties may participate live via telephone by registering at this conference call link. Please follow the link and register with a valid e-mail
Quarterly revenue of $741 million; GAAP EPS of $0.42 and adjusted EPS of $0.98 DALLAS, Aug. 08, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its second quarter 2024 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts. Q2 2024% Change Q2 2023YTD June 30, 2024% Change YTD June 30, 2023Revenue$740.7(25%)$1,561.6(26%)Gross profit$229.8(30%)$487.3(30%)Net income$16.2(73%)$33.6(77%)GAAP diluted EPS$0.42(73%)$0.88(75%)Adjusted diluted EPS*$0.98(59%)$1.95(60%)Adjusted EBITDA*$94.1(42%)$191.8(44%) * See "
DALLAS, July 12, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), has scheduled a conference call to discuss its second quarter 2024 financial results and third quarter 2024 outlook on Thursday, August 8, 2024, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time. A live webcast of the call can be accessed through this webcast link, which also will be available on AMN Healthcare's investor relations website. Interested parties may participate live via telephone by registering at this conference call link. Please follow the link and register with a valid e-mail add
Quarterly revenue of $821 million; GAAP EPS of $0.45 and adjusted EPS of $0.97 DALLAS, May 09, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2024 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts. Q1 2024% Change Q1 2023Revenue$820.9(27%) Gross profit$257.5(30%) Net income$17.3(79%) GAAP diluted EPS$0.45(78%) Adjusted diluted EPS*$0.97(61%) Adjusted EBITDA*$97.7(46%) * See "Non-GAAP Measures" below for a discussion of our use of non-GAAP items and the table entitled "Non-GAAP
DALLAS, April 09, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), has scheduled a conference call to discuss its first quarter 2024 financial results and second quarter 2024 outlook on Thursday, May 9, 2024, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time. A live webcast of the call can be accessed through this webcast link, which also will be available on AMN Healthcare's investor relations website. Interested parties may participate live via telephone by registering at this conference call link. Please follow the link and register with a valid e-mail addre
Quarterly revenue of $818 million;GAAP EPS of $0.33 and adjusted EPS of $1.32 DALLAS, Feb. 15, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its fourth quarter and full year 2023 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts. Q4 2023% Change Q4 2022Full Year 2023% Change Full Year 2022Revenue$818.3(27%)$3,789.3(28%)Gross profit$260.9(30%)$1,249.6(27%)Net income$12.5(85%)$210.7(53%)Diluted EPS$0.33(83%)$5.36(46%)Adjusted diluted EPS*$1.32(47%)$8.21(31%)Adjusted EBITDA*$104.0(40%)$579.1(32%)*
DALLAS, Feb. 01, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), has scheduled a conference call to discuss its fourth quarter and full year 2023 financial results and first quarter 2024 outlook on Thursday, February 15, 2023, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time. A live webcast of the call can be accessed through this webcast link, which also will be available on AMN Healthcare's investor relations website. Interested parties may participate live via telephone by registering at this conference call link. Please follow the link and register with a
Quarterly revenue of $853 million; GAAP EPS of $1.39 and adjusted EPS of $1.97 DALLAS, Nov. 02, 2023 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its third quarter 2023 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts. Q3 2023% Change Q3 2022YTD September 30, 2023% Change YTD September 30, 2022Revenue$853.5(25%)$2,971.0(28%)Gross profit$289.5(25%)$988.6(26%)Net income$53.2(42%)$198.2(45%)GAAP diluted EPS$1.39(34%)$4.99(38%)Adjusted diluted EPS*$1.97(23%)$6.86(27%)Adjusted EBITDA*$133.7(26%)$475.1(2
DALLAS, Oct. 05, 2023 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), has scheduled a conference call to discuss its third quarter 2023 financial results and fourth quarter 2023 outlook on Thursday, November 2, 2023, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time. A live webcast of the call can be accessed through this webcast link, which also will be available on AMN Healthcare's investor relations website. Interested parties may participate live via telephone by registering at this conference call link. Please follow the link and register with a valid e-mail a
These eleven mid-cap stocks were the best performers in the last week. Are they in your portfolio? Virtu Financial, Inc. (NASDAQ:VIRT) shares jumped 30.04% after reporting better-than-expected Q2 financial results. V.F. Corporation (NYSE:VFC) stock upped 22.38% after the company announced it entered into a Stock and Asset Purchase Agreement to sell its Supreme brand to EssilorLuxottica (OTC: ESLOF) for $1.5 billion in cash. Several analysts raised their price forecasts on VFC. New Fortress Energy Inc. (NASDAQ:NFE) shares grew 20.19% after the company announced that it achieved First LNG for its initial Fast LNG asset located offshore Altamira, Mexico. Riot Platforms Inc (NASDAQ:
Benchmark analyst Bill Sutherland reiterates AMN Healthcare Services (NYSE:AMN) with a Hold.
Analysts' ratings for AMN Healthcare Services (NYSE:AMN) over the last quarter vary from bullish to bearish, as provided by 7 analysts. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 5 1 0 0 Last 30D 0 0 1 0 0 1M Ago 1 2 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 3 0 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $75.14, a high estimate of $87.00, and a low estimate of $65.00. A decline of 8.56% from the prior average price target is evident in the current
B of A Securities analyst Kevin Fischbeck maintains AMN Healthcare Services (NYSE:AMN) with a Neutral and raises the price target from $61 to $65.
BMO Capital analyst Jeffrey Silber maintains AMN Healthcare Services (NYSE:AMN) with a Outperform and lowers the price target from $80 to $71.
Shares of Diodes Incorporated (NASDAQ:DIOD) fell sharply during Friday's session after the company reported worse-than-expected quarterly financial results. Diodes posted adjusted earnings of 28 cents per share, missing market estimates of 31 cents per share. The company's quarterly sales came in at $301.97 million missing expectations of $305.01 million, according to data from Benzinga Pro. Diodes shares dipped 9.8% to $68.99 on Friday. Here are some other stocks moving in today’s mid-day session. Gainers Novavax, Inc. (NASDAQ:NVAX) shares jumped 139% to $10.73 after the company and Sanofi announced a co-exclusive licensing agreement to commercialize a COVID-19 vaccine and d
JMP Securities analyst Constantine Davides reiterates AMN Healthcare Services (NYSE:AMN) with a Market Outperform and maintains $75 price target.
Second Quarter 2024 OutlookMetricGuidance*Consolidated revenue$730 - $750 millionGross margin30.7% - 31.2%SG&A as percentage of revenue21.5% - 22.0%Operating margin3.0% - 3.7%Adjusted EBITDA margin11.0% - 11.5%*Note: Guidance percentage metrics are approximate. For a reconciliation of adjusted EBITDA margin, see the table entitled "Reconciliation of Guidance Operating Margin to Guidance Adjusted EBITDA Margin" below.Revenue in the second quarter of 2024 is expected to be 24-26% lower than prior year and 9-11% lower sequentially. Nurse and Allied Solutions segment revenue is expected to be down 36-38% year over year. Physician and Leadership Solutions segment revenue is expected to grow app
AMN Healthcare Services (NYSE:AMN) reported quarterly earnings of $0.97 per share which beat the analyst consensus estimate of $0.96 by 1.04 percent. This is a 61.04 percent decrease over earnings of $2.49 per share from the same period last year. The company reported quarterly sales of $820.878 million which beat the analyst consensus estimate of $816.537 million by 0.53 percent. This is a 27.10 percent decrease over sales of $1.126 billion the same period last year.
DALLAS, Oct. 31, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE:AMN), the leader and innovator in total talent solutions for healthcare organizations, today announced the appointment of Tomya Watt as Chief People Officer effective January 13, 2025. With more than two decades of strategic and operational experience in healthcare and talent solutions, Ms. Watt is well-equipped to guide the company's human resources function into a new era of sustainable growth. "We are thrilled to welcome Tomya Watt to AMN Healthcare," said Cary Grace, AMN Healthcare's President and CEO. "Our exceptional team and culture distinguish us in the industry. Tomya's visionary leadership and extensive expertise
DALLAS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN) ("AMN" or "the Company"), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced that Brian Scott has been appointed Chief Financial Officer and Chief Operating Officer, effective November 21, 2024. In this role, Mr. Scott will be responsible for AMN's finance and enterprise operating functions as the Company continues to evolve its model to be more automated and scaled. Mr. Scott is returning to AMN, where he previously held a variety of roles of increasing responsibility in finance, strategy and accounting over his 17-year tenure, includin
DALLAS, July 31, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE:AMN) is taking steps to further strengthen its market-leading approach to total talent solutions in healthcare by creating a new Executive Advisory Board, which will be led by Mike Butler, former President of Providence. Consisting of accomplished leaders from various healthcare organizations, the Executive Advisory Board will serve as trusted advisors, leveraging their extensive industry expertise to unlock new market opportunities. Their work will center on ways to help healthcare organizations optimize their workforce planning and management. By deploying predictive analytics and workforce expertise, for example, health
DALLAS, July 09, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE:AMN) the leader in total talent solutions has appointed healthcare veteran Jim Hinton to the board of directors effective July 22. He brings an extensive background in healthcare with leadership, governance and operational expertise serving both as an executive officer and as a director of healthcare companies. Board Expansion with Skilled Leadership Currently serving as an Operating Partner on the Healthcare Team of Welsh, Carson, Anderson, Stowe, Mr. Hinton has navigated complex healthcare environments throughout his career. He previously served as the Chief Executive Officer of Baylor Scott & White Health, leading Texas's
DALLAS, Aug. 31, 2022 (GLOBE NEWSWIRE) -- International Esperanza Project (IEP), a Dallas-based nonprofit whose mission is to inspire hope in people in developing countries through healthcare and community infrastructure and education projects, today announced the appointment of Steve Wehn as Chair of the Board of Directors. Wehn, Vice President of Government Relations with AMN Healthcare, has been instrumental in the partnership between IEP and AMN, which has sponsored and partnered healthcare, community infrastructure and education missions to the impoverished highlands of Guatemala. Wehn, who served as Vice Chair and was a founding IEP director in 2017, succeeds Laura Wheat, who served
AMN Healthcare has been honored by the Women's Forum of New York as a national leader in female corporate board representation, achieving over 50% of Board of Directors' seats held by women, among the highest level of publicly traded companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211116005653/en/AMN Healthcare Board of Directors (L to R): R. Jeffrey Harris, Teri G. Fontenot, Mark G. Foletta, Sylvia Trent-Adams, Susan R. Salka, Martha H. Marsh, Douglas D. Wheat, Daphne E. Jones (Photo: Business Wire) "We are grateful to the Women's Forum for keeping the spotlight on this vitally important issue that brings much-needed c
AMN Healthcare (NYSE:AMN), the nation's largest total talent solutions provider in healthcare, announced the appointment of Jeffrey R. Knudson as the company's Chief Financial Officer. He will join the leadership team at AMN on November 2, 2021. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211014006027/en/AMN), the nation's largest total talent solutions provider in healthcare, announced the appointment of Jeffrey R. Knudson as the company's Chief Financial Officer. He will join the leadership team at AMN on November 2, 2021. "The AMN leadership team and Board of Directors are thrilled to have Jeff Knudson joining our organizat